Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3
NCT05738980
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
88
Enrollment
OTHER_GOV
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL:
Autologous RAK cells
Sponsor
Beijing Hospital